NCQA to Start Accrediting ACOs this Month

Patients with allergic rhinitis face prolonged symptoms and inadequate treatment, highlighting a need for better awareness and access to allergen immunotherapy.

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Central centrifugal cicatricial alopecia (CCCA) faces significant diagnostic delays, highlighting the need for increased awareness and education among providers.

This week's news roundup covers updates in health policy, technology, and access to pharmaceuticals.

Phase 2 trial results show anlotinib with anthracyclines and ifosfamide yields a 30.8% ORR and an 82.7% DCR in advanced soft tissue sarcoma.

At the Orlando session of the Institute for Value-Based Medicine, clinicians delivering cancer care in Central Florida address restrictions from Medicare Advantage plans, which can affect access to innovative treatments for breast cancer, myeloma, and bladder cancer.